Press Releases
Search
-
04 Nov 2015
bioMérieux introduces GENE-UP®, a new molecular diagnostic solution for food pathogen detection jointly developed with BioFire
New generation PCR system benefits from the combined expertise of bioMérieux, world leader in microbiological food safety control and of BioFire, reputed for its know-how in molecular biology...
-
22 Oct 2015
Information financière du 3e trimestre 2015
Robust growth in nine-month sales: Sales reached €1,412 million Up 18.3% as reported Up 8.3% at constant exchange rates and scope of consolidation Solid momentum in the Americas and EMEA1 regions in t...
-
09 Oct 2015
BioFire Diagnostics receives a de novo clearance by the FDA for the FilmArray® Meningitis/Encephalitis panel continuing its extremely favorable business momentum
FilmArray® expanded menu, with a fourth panel, is the largest available on a molecular biology multiplex platform...
-
24 Sep 2015
BioFire Defense, a bioMérieux company, receives Emergency Use Assessment and Listing for FilmArray® Ebola Test by the World Health Organization
Marcy l’Etoile (France) – September 24, 2015 – BioFire Defense, LLC of Salt Lake City, UT announces that its FilmArray® Ebola test (BioThreat-E test1) has received Emergency Use Assessment and Listing...
-
31 Aug 2015
bioMérieux – First-Half 2015 Results
Strong growth in business €933 million in sales Up 19.5% as reported Up 8.1% like-for-like Sharp 34% improvement in contributive operating income before non-recurring items lifted by strong business m...
-
27 Jul 2015
bioMérieux receives FDA 510(k) clearance for VIDAS® 3, the new generation of VIDAS®
Marcy l'Etoile, France, July 27, 2015 — bioMérieux, a world leader in the field of in vitro diagnostics, announces that VIDAS® 3, the new generation of VIDAS®, received FDA 510(k) clearance. This inst...
-
17 Jul 2015
First-Half 2015 Business Review
Strong growth in business €933 million in sales Up 19.5% as reported Up 8.1% like-for-like Fast-rising sales in the Americas, up 18.3%, and a return to more sustained expansion in the Asia-Pacific, up...
-
22 Jun 2015
Global experts engage in the fight against antimicrobial resistance during the World HAI/Resistance Forum organized by bioMérieux
For the Forum’s 5th edition, bioMérieux commits to support a global educational project on the fight against antimicrobial resistance recognized as a major global public health threat.
-
11 May 2015
2014 Financial Results
Solid growth in sales: Up 8.7%, including BioFire and at constant exchange rates Up 3.8%, at constant exchange rates and scope of consolidation Contributive operating income before non-recurring items...
-
23 Apr 2015
bioMérieux - First-Quarter 2015 Business Review
Strong growth in sales €448 million in sales Up 20.8% as reported Up 8.7% at constant exchange rates and scope of consolidation Sales off to a fast start in the Americas, up 19.6%* Strengthened positi...
-
14 Apr 2015
BioFire dépose auprès de la FDA une demande de novo pour le panel FilmArray® Méningite - Encéphalite
Marcy l’Etoile, France - April 14, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, today announced that BioFire, its molecular biology affiliate, has submitted a de novo classi...
-
26 Feb 2015
BioFire Receives FDA Clearance for the FilmArray® 2.0 System
New system delivers higher throughput, single database management and minimized footprint Marcy l’Etoile, France – February 26, 2015 – bioMérieux, a world leader in the field of in vitro diagnostics, ...
-
10 Feb 2015
BioFire Defense, a bioMérieux Company, Receives Prestigious Frost & Sullivan’s 2014 Global New Product Innovation Award for its FilmArray® Ebola Test
BioFire Defense, LLC is proud to announce that it is the recipient of the Frost & Sullivan’s 2014 Global New Product Innovation Award for its FilmArray® Ebola test. The New Product Innovation Award is...
-
22 Jan 2015
bioMérieux and Astute Medical sign a global agreement to develop and market NephroCheck® Test for VIDAS®, an assay to assess the risk of developing acute kidney injury
Marcy l’Etoile, (France) - San Diego, California (United States) - January 22, 2015 - bioMérieux, a world leader in the field of in vitro diagnostics, and Astute Medical, Inc., a company dedicated to ...
-
22 Jan 2015
Business Review for the Three Months and Full Year Ended December 31, 2014
Sales: solid growth, lifted sharply by BioFire Revenue: €1,698 million, up a reported 7% Up 8.7%, including BioFire and at constant exchange rates Up 3.8% at constant exchange rates and scope of conso...